Form 4: Inari Medical Director William Hoffman Sells 40,000 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director William Hoffman sold 40,000 shares of Inari Medical (NARI) common stock on October 29, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- William Hoffman, a director of Inari Medical, Inc. (NARI), sold 40,000 shares of common stock on October 29, 2024.
- The sales were executed in two transactions at a price of $50.1 and $50 per share.
- The transactions were conducted under a Rule 10b5-1 trading plan adopted on December 14, 2023.
- Following the reported transactions, Hoffman beneficially owns 561,233 shares of Inari Medical common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-existing trading plan and doesn't necessarily reflect a change in the director's view of the company's prospects.
Industry Context
Sales by insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically views such sales in the context of the overall insider ownership and the reasons behind the sale.
Key Dates
| Date | Description |
|---|---|
| 2023-12-14 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 2024-10-29 | Date of the stock sale transactions |
| 2024-10-31 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.